share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K：外國發行人報告
美股sec公告 ·  04/19 05:27
牛牛AI助理已提取核心訊息
Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.
Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.
Bruush Oral Care Inc.在向美國證券交易委員會提交的6-K表格中報告說，在一名董事會成員於2023年4月12日辭去審計委員會職務後，該公司目前不遵守納斯達克審計委員會的要求。該公司獲准在2024年4月12日之前恢復合規，但未能這樣做。起亞·貝沙拉特因不符合獨立要求於2024年4月10日辭去了審計委員會主席兼成員的職務，儘管他仍然是董事會的獨立董事。Bruush Oral Care已要求納斯達克聽證會小組舉行聽證會，對定於2024年4月25日進行的證券退市提出上訴。該公司於2024年4月15日收到通知，稱其違規行爲是從納斯達克股票市場退市的另一個依據。該公司已向專家小組提交了合規計劃，但無法保證專家小組的決定。
Bruush Oral Care Inc.在向美國證券交易委員會提交的6-K表格中報告說，在一名董事會成員於2023年4月12日辭去審計委員會職務後，該公司目前不遵守納斯達克審計委員會的要求。該公司獲准在2024年4月12日之前恢復合規，但未能這樣做。起亞·貝沙拉特因不符合獨立要求於2024年4月10日辭去了審計委員會主席兼成員的職務，儘管他仍然是董事會的獨立董事。Bruush Oral Care已要求納斯達克聽證會小組舉行聽證會，對定於2024年4月25日進行的證券退市提出上訴。該公司於2024年4月15日收到通知，稱其違規行爲是從納斯達克股票市場退市的另一個依據。該公司已向專家小組提交了合規計劃，但無法保證專家小組的決定。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。